Sarissa Consulting’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Sarissa Consulting’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-150,000	Closed	-$1.72M	–	64
2021 Q4	$1.72M	Buy	+150,000	New	+$1.69M	2.21%	15

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Sarissa Consulting's NFH Position: Q1 2022 in Review

Sarissa Consulting sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 150,000 shares — an estimated $1.72M sold.

Sarissa Consulting first reported a position in NFH in Q4 2021 and held it in 1 quarter. The position peaked at $1.72M in Q4 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

Sarissa Consulting reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Sarissa Consulting sold 150,000 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $1.72M.
Sarissa Consulting first reported a position in New Frontier Health Corporation Ordinary Shares in Q4 2021 and held it in 1 quarter.
Sarissa Consulting's New Frontier Health Corporation Ordinary Shares position peaked at $1.72M in Q4 2021.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Sarissa Consulting's 13F filing for Q1 2022, filed 16 May 2022.